Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma

  1. Morante, M.
  2. Pandiella, A.
  3. Crespo, P.
  4. Herrero, A.
Aldizkaria:
Biomolecules

ISSN: 2218-273X

Argitalpen urtea: 2022

Alea: 12

Zenbakia: 11

Mota: Berrikuspena

DOI: 10.3390/BIOM12111562 GOOGLE SCHOLAR lock_openSarbide irekia editor